Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.95% | 9.22% | 3.66% | 9.81% | -11.94% |
| Total Depreciation and Amortization | -7.20% | -6.53% | -7.88% | -3.63% | -9.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.95% | -29.84% | -46.43% | -11.82% | 75.48% |
| Change in Net Operating Assets | 139.99% | -436.38% | 386.30% | -183.82% | -34.82% |
| Cash from Operations | 64.35% | -126.85% | 64.53% | 1.22% | -16.03% |
| Capital Expenditure | 41.67% | 22.22% | 73.91% | 69.32% | 82.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 41.67% | 22.22% | 73.91% | 69.32% | 82.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 8.92% | -7.31% | -6.98% | -7.11% | -4.56% |
| Issuance of Common Stock | -59.50% | 186.70% | -37.45% | -- | 353.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.25% | 190.90% | -39.40% | 5,438.27% | 442.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.11% | 43.54% | 644.81% | 106.19% | 79.70% |
